Profilo
Dr. Michael Perkins, MD, is Chief Medical Officer & Development Director at Oxagen Ltd.
Dr. Perkins was previously employed as Chief Development Officer by Ionix Pharmaceuticals Ltd., a Principal by AstraZeneca Plc, and Vice President-Worldwide Regulatory Affairs by Pfizer Ltd.
He received his doctorate degree from the University of Leeds.
Precedenti posizioni note di Michael Perkins
| Società | Posizione | Fine |
|---|---|---|
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Consigliere Generale | - |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Direttore Tecnico/Scientifico/R&S | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Ionix Pharmaceuticals Ltd.
Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops analgesic medicines | Corporate Officer/Principal | - |
Formazione di Michael Perkins
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Ionix Pharmaceuticals Ltd.
Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops analgesic medicines | Health Technology |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Health Technology |
















